Immunologic characterization of natural and recombinant Mal f 1 yeast allergen
Summary
This summary is machine-generated.Recombinant Malassezia furfur allergen 1 (rMal f 1) was successfully produced in E. coli and insect cells. This recombinant allergen mimics natural Mal f 1, enabling accurate diagnosis of IgE-mediated allergies in atopic dermatitis patients.
Area Of Science
- Allergen recombinant protein expression
- Immunology
- Atopic Dermatitis Research
Background
- Atopic dermatitis (AD) patients often exhibit IgE antibodies to Malassezia furfur.
- The cDNA for Mal f 1, a protein component of M. furfur, has been identified.
Purpose Of The Study
- To express large quantities of recombinant Mal f 1 (rMal f 1) using diverse expression systems.
- To compare the IgE-binding capabilities of rMal f 1 with natural Mal f 1.
Main Methods
- Mal f 1 was expressed and purified from prokaryotic (E. coli) and eukaryotic (baculovirus-infected insect) cells.
- Recombinant Mal f 1's IgE-binding was assessed using immunoblotting and CAP System RAST FEIA with patient sera.
Main Results
- Positive IgE-binding RAST responses were observed in 61% of patients using baculovirus-produced rMal f 1 and 43% using E. coli-produced rMal f 1.
- Both recombinant proteins inhibited IgE binding to natural Mal f 1, indicating preservation of key epitopes.
- Recombinant Mal f 1 induced histamine release from basophils of an atopic individual.
Conclusions
- Successfully expressed and purified rMal f 1 exhibits IgE-binding properties similar to natural Mal f 1.
- Production of recombinant allergens with native-like properties facilitates accurate diagnosis of IgE-mediated allergies.
View abstract on PubMed